SCHEMBL6028969

SCHEMBL6028969

Cc1nc2cc(OC[C@H](O)CC3CNCCN3)ccc2s1

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6191510 0.81 PDE3B (0.34)
SCHEMBL5353655 0.78 CYP3A4 (0.51) CYP3A4
SCHEMBL4038742 0.78 CYP3A4 (0.51) CYP3A4
SCHEMBL5901420 0.77 CYP3A4 (0.52) CYP3A4
SCHEMBL5965179 0.77 CYP3A4 (0.52) CYP3A4
SCHEMBL4859620 0.76 CYP3A4 (0.63) CYP3A4CYP1A2CYP2C9
SCHEMBL4329581 0.76 CYP3A4 (0.63) CYP3A4CYP1A2CYP2C9
SCHEMBL4038101 0.76 CYP3A4 (0.63) CYP3A4CYP1A2CYP2C9
SCHEMBL773180 0.76 CYP3A4 (0.54) CYP3A4CYP1A2CYP2C9
Hydrochloric Acid SCHEMBL5901203 0.76 CYP3A4 (0.62) CYP3A4CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723129-A1 1-AKAN-2-OL SUBSTITUTED PIPERAZINE AND PIPERIDINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2006-11-22 EP disclosed
EP-1583751-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES CV THERAPEUTICS, INC. (US) 2005-10-12 EP disclosed
EP-1583760-A2 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV Therapeutics Inc. (US) 2005-10-12 EP disclosed
WO-2005061470-A1 1-AKAN-2-OL SUBSTITUTED PIPERAZINE AND PIPERIDINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2005-07-07 WO disclosed
WO-2004069818-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES CV THERAPEUTICS INC. (US) 2004-08-19 WO disclosed
WO-2004067506-A2 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV THERAPEUTICS INC. (US) 2004-08-12 WO disclosed